Search Symbol

Most Active Stocks

BSE

PAYTM

INFY

HDFCBANK

RPOWER

TCS

CDSL

BHARTIARTL

TANLA

RELIANCE

COCHINSHIP

BAJFINANCE

ICICIBANK

SBIN

ROUTE

TATAMOTORS

ONGC

MAZDOCK

INDIGO

Wockhardt Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Wockhardt Limited, a pharmaceutical and biotech company, manufactures and trades pharmaceuticals, medicinal, botanical, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. The company develops qualified infectious diseases products comprising WCK5222, which is in phase 3 clinical trial for the treatment of sepsis and hospital/ventilator associated pneumonia; WCK 4282, which is in phase 3 clinical trial for ESBL infections; WCK 6777, which is phase 1 to treat gram negative infections; and WCK 4873, which is phase 3 clinical trial for community-acquired bacterial pneumonia. It also offers rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company develops and commercializes Biovac-B, a hepatitis B vaccine; WEPOX, a recombinant human erythropoietin; WOSULIN, a recombinant human insulin; and GLARITUS, a recombinant insulin glargine. Further, it provides contract manufacturing services; offers and active pharmaceutical ingredients. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.

Key Information

Market Cap

258044018688

Current Price

1588.1

52 Week Range

552.0 - 1679.9

Previous Close

1546.6

Open

1555.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Wockhardt Towers, Bandra Kurla Complex Bandra (East), Mumbai, 400051, India

Phone

+91-24066-94444

Website

https://www.wockhardt.com

Financials

Day Low

1545.0

Day High

1591.1

Dividend Yield

PE Ratio

Earnings Per Share

-3.09

Beta

1.155

EBITDA

3969999872

Book Value

273.368

EPS

Company Officers

Name	Title	Age	Year Born
Dr. Habil Fakhruddin Khorakiwala	Founder & Executive Chairman	83	1941
Dr. Murtaza Habil Khorakiwala	MD & Executive Director	51	1973
Dr. Huzaifa Habil Khorakiwala	Executive Director	53	1971
Mr. Deepak R. Madnani	Chief Financial Officer	-	-
Dr. Mahesh Vithalbhai Patel	Chief Scientific Officer of New Drug Discovery	-	-
Ms. Debolina Partap	Senior Vice President of Legal	-	-
Mr. Neeraj Agarwal	Chief Human Resource Officer	-	-
Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA	Senior Vice President of Business Development	73	1951
Mr. Zoher T. Sihorwala	Head of Global Regulatory Affairs	54	1970
Mr. Prakash Gupta	President of Supply Chain	-	-